Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Research and development (R&D) of Structural Heart products, chiefly DurAVR THV (Transcatheter Heart Valve) for the treatment of aortic stenosis and its ComASUR delivery system which allows accurate ...